ifosfamide has been researched along with Cancer of Testis in 225 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the role of single agent carboplatin chemotherapy in patients with metastatic seminoma based on the data from two randomised trials." | 9.11 | Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials. ( Bokemeyer, C; Clemm, C; Gerl, A; Hartmann, JT; Horwich, A; Kanz, L; Kollmannsberger, C; Meisner, C; Oliver, T; Rückerl, CP; Schmoll, HJ; Stenning, S, 2004) |
| "This prospective phase II study assesses the clinical efficacy and complications of a treatment regimen comprising combination chemotherapy with carboplatin and ifosfamide and selective consolidation in advanced seminoma." | 9.08 | Carboplatin and ifosfamide and selective consolidation in advanced seminoma. ( Amato, RJ; Banks, M; Ellerhorst, J; Logothetis, CJ, 1995) |
| "Ifosfamide/mesna has modest activity in malignant mesothelioma." | 9.07 | A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study. ( Balcerzak, SP; Berenberg, JL; Keppen, MD; Metch, B; Militello, L; Pierce, HI; Zidar, BL, 1992) |
| " We report the first case of delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen." | 7.85 | Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report. ( Anwer, F; Chan, O; Hamdani, AA; Sokolova, A; Ullah, W, 2017) |
| "The efficacy of ifosfamide combination chemotherapy was studied in 164 patients, 94 with advanced testicular carcinoma and 70 with metastatic sarcoma." | 7.66 | Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomas. ( Cremer, M; Niederle, N; Scheulen, ME; Schmidt, CG; Schütte, J; Seeber, S, 1983) |
| "To study the role of single agent carboplatin chemotherapy in patients with metastatic seminoma based on the data from two randomised trials." | 5.11 | Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials. ( Bokemeyer, C; Clemm, C; Gerl, A; Hartmann, JT; Horwich, A; Kanz, L; Kollmannsberger, C; Meisner, C; Oliver, T; Rückerl, CP; Schmoll, HJ; Stenning, S, 2004) |
| "This prospective phase II study assesses the clinical efficacy and complications of a treatment regimen comprising combination chemotherapy with carboplatin and ifosfamide and selective consolidation in advanced seminoma." | 5.08 | Carboplatin and ifosfamide and selective consolidation in advanced seminoma. ( Amato, RJ; Banks, M; Ellerhorst, J; Logothetis, CJ, 1995) |
| "High-dose ifosfamide is associated with severe but usually reversible myocardial depression and malignant arrhythmias." | 5.07 | High-dose ifosfamide is associated with severe, reversible cardiac dysfunction. ( Bryant, G; Cunnion, RE; Ognibene, FP; Parker, MM; Quezado, ZM; Reda, D; Wilson, WH, 1993) |
| "Ifosfamide/mesna has modest activity in malignant mesothelioma." | 5.07 | A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study. ( Balcerzak, SP; Berenberg, JL; Keppen, MD; Metch, B; Militello, L; Pierce, HI; Zidar, BL, 1992) |
| " Those with high volume metastases will receive either BEP or etoposide, ifosfamide and cisplatinum (VIP)." | 5.06 | Potential advances in combination chemotherapy for advanced testicular cancer. ( Boven, E; De Pauw, M; Harris, A; Jones, W; Kaye, SB; Sleijfer, D; Splinter, T; Stoter, G; Ten Bokkel Huinink, W; Van Oosterom, A, 1988) |
| "The activity of ifosfamide in genitourinary malignancies has been documented in testicular cancer and bladder cancer." | 4.79 | The role of ifosfamide in the treatment of testicular and urothelial malignancies. ( Roth, BJ, 1996) |
| "The alkylating agent ifosfamide, an analog of cyclophosphamide, has demonstrated significant activity in soft tissue sarcoma and testicular carcinoma." | 4.77 | Ifosfamide. ( Baker, LH; Zalupski, M, 1988) |
| " We report the first case of delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen." | 3.85 | Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report. ( Anwer, F; Chan, O; Hamdani, AA; Sokolova, A; Ullah, W, 2017) |
| "Herein we present a unique case report of a 47-year- old man with metastatic adenocarcinoma of rete testis who achieved substantial disease response after four cycles of paclitaxel, ifosfamide and cisplatin." | 3.80 | Adenocarcinoma of the rete testis - a rare case of testicular malignancy. ( Chovanec, M; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Rajec, J; Sycova-Mila, Z, 2014) |
| "The efficacy of ifosfamide combination chemotherapy was studied in 164 patients, 94 with advanced testicular carcinoma and 70 with metastatic sarcoma." | 3.66 | Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomas. ( Cremer, M; Niederle, N; Scheulen, ME; Schmidt, CG; Schütte, J; Seeber, S, 1983) |
| "Eleven patients had localized testicular tumors (median age 0." | 2.80 | Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study. ( Castex, MP; Faure-Conter, C; Fresneau, B; Kalfa, N; Martelli, H; Orbach, D; Patte, C; Verité, C, 2015) |
| "Paclitaxel was added to high-dose (HD) etoposide, ifosfamide, and cisplatin (VIP; etoposide 1,500 mg/m2, ifosfamide 10,000 mg/m2, and cisplatin 100 mg/m2; cumulative dose; days -6 through -2 per cycle) at three dose levels (135, 175, and 225 mg/m2) applied on day -6." | 2.73 | Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. ( Beyer, J; Bokemeyer, C; Casper, J; Derigs, G; Gauler, T; Gerl, A; Hartmann, JT; Horger, M; Kuczyk, MA; Mayer-Steinacker, R; Metzner, B; Rick, O; Schleicher, J, 2007) |
| "Eight patients with advanced germ cell cancer were treated with TIP that was originally reported by Motzer et al (1)." | 2.71 | Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer. ( Akaza, H; Hattori, K; Hinotsu, S; Kawai, K; Miyazaki, J; Shimazui, T; Tsukamoto, S, 2003) |
| " The results however, did not show expected treatment efficacy and we raise the idea of paclitaxel dosage relevance in TIP." | 2.71 | Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. ( Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Sálek, T; Sycová-Milá, Z, 2005) |
| "Since 1980, 73 patients with advanced testicular cancer have been treated with chemotherapy and 43 patients received post-chemotherapy (salvage) surgery." | 2.69 | [Results of chemotherapy and salvage surgery for advanced testicular cancer]. ( Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Miki, T; Saiki, S; Usami, M, 1999) |
| "More effective high-dose combination regimens are needed which have broad cytotoxic activity, steep dose-response relations and non-overlapping non-hematologic toxicities (to allow administration of full doses of each agent)." | 2.68 | Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. ( Ayash, LJ; Elias, AD; Frei, E; Gonin, R; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C, 1995) |
| "Of 21 patients with testicular tumors who could be evaluated, 10 (47%) achieved a CR." | 2.68 | High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. ( André, T; Bonnak, H; Bouleuc, C; Donsimoni, R; Esteso, A; Firmin, C; Gerota, J; Izrael, V; Lotz, JP; Merad, Z, 1995) |
| "Ifosfamide was given at the dosage of 2." | 2.67 | Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results. ( Faustini, M; Gianni, L; Nicolai, N; Piva, L; Pizzocaro, G; Salvioni, R, 1992) |
| " A daily dosage of 50 to 60 mg/kg ifosfamide on 5 consecutive days produced the best results." | 2.64 | Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide. ( Brock, N; Burkert, H; Fichtner, E; Schnitker, J, 1976) |
| "The chemotherapy in testis and penis neoplasms knew few advances in recent years." | 2.49 | [Chemotherapy in male external genital organs (testicular and penile cancer)]. ( Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G, 2013) |
| "Patients with relapsed germ cell tumors (GCT) are potentially curable despite the failure of initial cisplatin based therapy." | 2.48 | Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy. ( Lim, L; Powles, T; Rashid, S, 2012) |
| "Paclitaxel has also been proved effective both as monotherapy in heavily-pretreated cases and as part of first-line salvage regimens; the combination of paclitaxel-ifosfamide-cisplatin, followed or not by high-dose chemotherapy, induced a favorable long-term disease-free survival rate, especially in patients with good prognosis." | 2.43 | Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors. ( Farmakis, D; Pectasides, D; Pectasides, M, 2005) |
| "Clinicians should be aware of the potential neurovascular adverse effects of cisplatin-based protocols." | 2.42 | Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide. ( Bogdahn, U; Dietrich, J; Marienhagen, J; Schalke, B; Schlachetzki, F, 2004) |
| "The treatment strategy for testicular cancer using chemotherapy has been well established and has been shown to be successful." | 2.41 | [Chemotherapy and radiotherapy for urological cancer]. ( Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K, 2002) |
| "For patients with far advanced testicular cancer, who only have a chance of long-term cure in the range of 40% to 50% by standard induction chemotherapy, the German Testicular Cancer Study Group has shown that the application of GM-CSF after PEI chemotherapy has allowed the increase of dose intensity of this three-drug regimen by a factor of 1." | 2.39 | The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group. ( Bokemeyer, C; Clemm, C; Harstrick, A; Illiger, HJ; Link, H; Metzner, B; Ostermann, H; Rüther, U; Schmoll, HJ; Siegert, W, 1994) |
| "Ifosfamide has single-agent activity comparable to etoposide in very poor-prognosis, cisplatin-refractory disease." | 2.39 | Ifosfamide in the treatment of germ cell tumors. ( Nichols, CR, 1996) |
| "Ifosfamide has the broad range of clinical activity, but its ultimate role as part of initial therapy remains to be discerned." | 2.38 | Clinical trials with ifosfamide: the Indiana University experience. ( Einhorn, LH; Loehrer, PJ; Nichols, CR; Williams, SD, 1992) |
| "Ifosfamide has demonstrated significant activity as salvage therapy in patients with testicular tumors refractory to cisplatin-containing induction chemotherapy regimens." | 2.38 | Ifosfamide in testicular cancer. ( Loehrer, PJ, 1990) |
| "Patients with testicular cancer who relapse after primary chemotherapy are still curable and should be treated aggressively with this goal in mind." | 2.38 | Salvage therapy in recurrent testicular cancer. ( Saxman, S, 1992) |
| "From the Danish Testicular Cancer database, we identified all patients who received more than one line of treatment for disseminated disease." | 1.42 | Germ Cell Cancer and Multiple Relapses: Toxicity and Survival. ( Agerbaek, M; Bandak, M; Daugaard, G; Gupta, R; Holm, NV; Kier, MG; Lauritsen, J; Mortensen, MS, 2015) |
| "Some children with extracranial germ cell tumors (GCT) relapse after or do not respond to first-line treatment combining chemotherapy and surgery, of whom very few experience long-term survival despite multimodal salvage treatment." | 1.40 | Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience. ( Baranzelli, MC; Corradini, N; Cropet, C; Fasola, S; Faure-Conter, C; Frappaz, D; Kalfa, N; Martelli, H; Orbach, D; Patte, C; Rocourt, N; Rome, A; Thebaud, E; Vérité, C, 2014) |
| "A 49-year-old patient with malignant germ cell tumor within the first cycle PEB (platinum [P], etoposid [E] and bleomycin [B]) presented with an itchy linear papular erythema with discrete vesicles." | 1.40 | [Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor]. ( Elsner, P; Grimm, MO; Schummer, C; Tittelbach, J; Winkler, Y, 2014) |
| "In adolescents aged 10-15 years germ cell tumors of the testis (TGCT) are rare and information for a risk adapted therapy limited." | 1.40 | Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients. ( Calaminus, G; Göbel, U; Haas, R; Harms, D; Leuschner, I; Schneider, DT; Schönberger, S; Teske, C, 2014) |
| "Eleven patients with advanced germ cell tumor refractory or relapsed after cisplatin-based chemotherapy were treated using docetaxel, ifosfamide and nedaplatin." | 1.39 | Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report. ( Arai, Y; Ishidoya, S; Ito, A; Kaiho, Y; Mitsuzuka, K; Miyazato, M; Nakagawa, H; Namiki, S; Ohara, S; Saito, H; Yamada, S; Yamashita, S, 2013) |
| "Late relapses following stage I germ cell tumors were associated with seminoma, older age, and worse outcome after induction chemotherapy." | 1.39 | Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival. ( Bulanov, A; Burova, A; Fainshtein, I; Fedyanin, M; Figurin, K; Garin, A; Kanagavel, D; Sergeev, U; Tjulandin, S; Tryakin, A; Zakharova, T, 2013) |
| "Adult extrarenal nephroblastomas (Wilms' tumor) are extremely rare tumors." | 1.37 | The first case of primary testicular germ cell tumor containing nephroblastoma as the only one non-germ cell component. ( Aksu, C; Başaran, M; Bavbek, S; Ekenel, M; Keskin, S; Kiliçaslan, I; Tunç, M, 2011) |
| "In relapsed germ cell tumors, salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) is a well-established regimen for patients with favorable features such as a primary testicular tumor and prior complete remission (CR) after the initial chemotherapy." | 1.37 | Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors. ( Kang, WK; Lee, J; Lee, S; Lim, HY; Park, JO; Park, S; Park, SH; Park, YS, 2011) |
| "Histology of the primary germ cell tumor was pure seminoma in 14 (27%), and non-seminoma in 30 (59%)." | 1.36 | [Result of treatment for advanced germ cell tumor in the last decade]. ( Fukuda, H; Fukui, N; Higashi, Y; Hyochi, N; Ichiyanagi, N; Inoue, M; Ishioka, J; Kageyama, Y; Numao, N; Saito, K; Tanak, M, 2010) |
| "A 30-year-old man was diagnosed with testicular cancer, and underwent a radical orchiectomy." | 1.35 | [A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin]. ( Egawa, S; Hatano, T; Ito, H; Kishimoto, K; Tomita, M; Wada, T; Yanada, S, 2008) |
| "The amazing results in testicular cancer were possible by consistent performance of clinical trials." | 1.34 | [Inductive systemic therapy of urological tumors with curative intent]. ( Krege, S; Rübben, H; vom Dorp, F, 2007) |
| "One patient developed a secondary acute myeloid leukemia (s-AML) involving a chromosomal translocation t(11;19)(q23;p13." | 1.33 | Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer. ( Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J, 2005) |
| "Paclitaxel is a potent anticancer agent against a variety of solid cancers." | 1.33 | [Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer]. ( Kawauchi, A; Mikami, K; Miki, T; Mizutani, Y; Nakamura, T; Nakanishi, H; Nomoto, T, 2006) |
| "To assess the role of residual tumor resection performed after high-dose chemotherapy (HDCT) in patients with relapsed or refractory germ cell tumors (GCT)." | 1.32 | Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. ( Beyer, J; Bokemeyer, C; Braun, T; Hartmann, JT; Hartmann, M; Pottek, T; Rachud, B; Rick, O; Schirren, J; Siegert, W; Weinknecht, S; Weissbach, L, 2004) |
| "HDC for testicular cancer was recently developed." | 1.32 | Fertility after high-dose chemotherapy for testicular cancer. ( Fujisawa, M; Ishikawa, T; Kamidono, S, 2004) |
| " Adverse effects on oral mucosa have been documented for several cytotoxic treatment regimens." | 1.30 | Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study. ( Fosså, SD; Herlofson, BB; Norman-Pedersen, K; Redfors, M, 1997) |
| "Five patients with metastatic testicular cancer of advanced extent according to the Indiana University criteria were enrolled into this study." | 1.30 | [High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) For advanced testicular cancer]. ( Arisawa, C; Fujii, Y; Ishizaka, K; Kageyama, Y; Kamata, S; Kihara, K; Komatsu, F; Masuda, H; Oshima, H; Tsujii, T, 1998) |
| "Four patients with advanced testis cancer were treated by high-dose chemotherapy supporting by autologous peripheral blood stem cell transplantation." | 1.30 | [High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer]. ( Akasaka, Y; Igarashi, H; Kondou, N; Kuroda, A; Madarame, J; Nakata, J; Ohishi, Y; Tomita, M; Yanada, S, 1998) |
| "We report a case of relapsed testicular tumor complicated by neutropenic enterocolitis during high dose chemotherapy with PBSCT." | 1.30 | [A case of neutropenic enterocolitis in high dose chemotherapy with peripheral blood stem cell transplantation for relapsed testicular tumor]. ( Haga, N; Honda, K; Itoh, M; Muraki, O; Ohto, H; Tsuruya, Y; Yamaguchi, O, 1998) |
| "For giant testicular tumor with extensive invasion to the spermatic cord, initial chemotherapy followed by surgical resection appears to be a better management." | 1.30 | [Two cases of giant testicular tumor with widespread extension to the spermatic cord: usefulness of upfront chemotherapy]. ( Fukui, I; Izutani, T; Kin, T; Kitsukawa, S; Maeda, Y; Shishido, T; Yonese, J, 1999) |
| " Poor performance status and prior radiotherapy were risk factors for fatal adverse effects." | 1.30 | [Treatment of advanced testicular cancer and toxicity of chemotherapy]. ( Kawakita, M; Matsuda, T; Terachi, T; Yoshida, O, 1999) |
| " Dose-response curves for cisplatin (3-30 000 nmol) combined with non-toxic silibinin doses (7." | 1.29 | Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. ( Bokemeyer, C; Dunn, T; Fels, LM; Gaedeke, J; Lentzen, H; Schmoll, HJ; Stolte, H; Voigt, W, 1996) |
| "Four of the patients had palpable testicular tumors, 3 had occult testicular tumors." | 1.29 | Intratesticular effects of cisplatin-based chemotherapy. ( Dieckmann, KP; Loy, V, 1995) |
| "Patients with relapsed germ cell cancer (GCT) have a poor prognosis when treated solely with conventional chemotherapy; high dose chemotherapy with autologous bone marrow rescue (ABMR) has shown curative potential in patients with relapsed and refractory GCT." | 1.29 | Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. ( Broun, ER; Einhorn, LH; Lazarus, HM; Loehrer, PJ; Nichols, CR; Roth, BJ; Turns, M; Williams, SD, 1994) |
| "In both human testicular cancer cell lines, H 12." | 1.29 | The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna. ( Bokemeyer, C; Casper, J; Dunn, T; Harstrick, A; Ludwig, E; Schmoll, HJ, 1994) |
| "Recently, specific chromosomal abnormalities have been described for several solid tumor malignancies." | 1.29 | Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. ( Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E, 1995) |
| "Ifosfamide has a similar spectrum of antitumor activity but has different pharmacokinetics that could provide advantages in efficacy." | 1.28 | Ifosfamide vs cyclophosphamide in cancer therapy. ( Weiss, RB, 1991) |
| "Forty-eight patients with advanced testicular cancer, defined as abdominal mass greater than 10 cm, mediastinal mass greater than 5 cm, more than 20 lung metastases, or visceral organ involvement were treated with an intensive, alternating five-drug regimen consisting of cisplatin 50 mg/m2 d 1-3, etoposide 170 mg/m2 d 1-3, ifosfamide 5 g/m2 d 15, vincristine 2 mg weekly, bleomycin 15 mg/m2 weekly, q d 28." | 1.28 | Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma. ( Bergmann, L; Dölken, G; Harstrick, A; Hohnloser, J; Köhne-Wömpner, CH; Lammers, U; Natt, F; Reichhardt, P; Schmoll, HJ; Siegert, W, 1991) |
| "The antitumor activity of ifosfamide in testicular cancer was not reduced by mesna." | 1.27 | Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients. ( Bremer, K; Niederle, N; Scheulen, ME; Schütte, J; Seeber, S, 1983) |
| "Ifosfamide (Holoxan) has an effect as a single drug on testicular carcinoma and shows synergism with cisplatinum in mice." | 1.26 | The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy. ( Clemm, C; Hartenstein, R; Wilmanns, W, 1982) |
| "Advanced malignant testicular tumors can be treated very successfully by chemotherapy." | 1.26 | [Modern chemotherapy of a malignant testicular tumors (author's transl)]. ( Arnold, H; Fiebig, HH, 1981) |
| "Of 250 testicular tumors treated up to May 1975 233 (93." | 1.26 | The combined surgical and chemotherapeutic approach to non-seminomatous cancer of the testicle. ( Vahlensieck, W; Weissbach, L, 1977) |
| "153 patients with inoperable malignant tumors were treated by the so-called synchronization therapy with vincristine and ifosfamide." | 1.26 | [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)]. ( Hartwich, G; Lutz, H; Neidhardt, B, 1978) |
| "12 patients with extensive metastases of malignant testicular tumors and 5 other patients with other rapidly growing metastasizing tumors were treated." | 1.25 | [Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)]. ( Jonas, U; Körner, F; Lund, S, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (19.56) | 18.7374 |
| 1990's | 77 (34.22) | 18.2507 |
| 2000's | 56 (24.89) | 29.6817 |
| 2010's | 45 (20.00) | 24.3611 |
| 2020's | 3 (1.33) | 2.80 |
| Authors | Studies |
|---|---|
| Connolly, EA | 1 |
| Weickhardt, A | 1 |
| Grimison, P | 1 |
| Asher, R | 1 |
| Heller, GZ | 1 |
| Lewin, J | 1 |
| Liow, E | 1 |
| Toner, G | 1 |
| Tung, ILY | 1 |
| Tran, B | 1 |
| Hill, S | 1 |
| Walpole, E | 1 |
| McKenzie, J | 1 |
| Kuchel, A | 1 |
| Goh, J | 1 |
| Forgeson, G | 1 |
| Tan, A | 1 |
| Joshi, A | 1 |
| Wickham, A | 1 |
| Tan, H | 1 |
| Wang, Y | 1 |
| Winstanley, MA | 1 |
| Hamad, N | 1 |
| Wong, V | 1 |
| Ramanathan, S | 1 |
| Prasad, M | 1 |
| Vora, T | 1 |
| Badira, CP | 1 |
| Kembhavi, S | 1 |
| Ramadwar, M | 1 |
| Khanna, N | 1 |
| Laskar, S | 1 |
| Muckaden, MA | 1 |
| Qureshi, S | 1 |
| Banavali, S | 1 |
| Chinnaswamy, G | 1 |
| Gordon, K | 1 |
| Ahmad, N | 1 |
| Sokolova, A | 1 |
| Chan, O | 1 |
| Ullah, W | 1 |
| Hamdani, AA | 1 |
| Anwer, F | 1 |
| Chi, EA | 1 |
| Schweizer, MT | 1 |
| Calaminus, G | 2 |
| Frappaz, D | 2 |
| Kortmann, RD | 1 |
| Krefeld, B | 1 |
| Saran, F | 1 |
| Pietsch, T | 1 |
| Vasiljevic, A | 1 |
| Garre, ML | 1 |
| Ricardi, U | 1 |
| Mann, JR | 1 |
| Göbel, U | 2 |
| Alapetite, C | 1 |
| Murray, MJ | 1 |
| Nicholson, JC | 1 |
| Richie, JP | 1 |
| Razafimahefa, J | 1 |
| Gosset, C | 1 |
| Culine, S | 6 |
| Mongiat-Artus, P | 1 |
| Verine, J | 1 |
| Albany, C | 1 |
| Bonnet, E | 1 |
| Tartas, S | 1 |
| Lazareth, A | 1 |
| Jaouen, A | 1 |
| Tamarelle, B | 1 |
| You, B | 1 |
| Maillet, D | 1 |
| Yamada, S | 1 |
| Saito, H | 1 |
| Ohara, S | 1 |
| Yamashita, S | 1 |
| Mitsuzuka, K | 1 |
| Namiki, S | 1 |
| Miyazato, M | 1 |
| Kaiho, Y | 1 |
| Ito, A | 1 |
| Nakagawa, H | 1 |
| Ishidoya, S | 1 |
| Arai, Y | 1 |
| Al-Hader, AA | 1 |
| Jain, A | 1 |
| Al-Nasrallah, N | 1 |
| Einhorn, LH | 11 |
| Faure-Conter, C | 2 |
| Orbach, D | 2 |
| Cropet, C | 1 |
| Baranzelli, MC | 1 |
| Martelli, H | 3 |
| Thebaud, E | 1 |
| Vérité, C | 2 |
| Rome, A | 1 |
| Fasola, S | 1 |
| Corradini, N | 1 |
| Rocourt, N | 1 |
| Kalfa, N | 2 |
| Patte, C | 2 |
| Fizazi, K | 5 |
| Delva, R | 4 |
| Caty, A | 2 |
| Chevreau, C | 3 |
| Kerbrat, P | 2 |
| Rolland, F | 3 |
| Priou, F | 1 |
| Geoffrois, L | 4 |
| Rixe, O | 1 |
| Beuzeboc, P | 1 |
| Malhaire, JP | 2 |
| Aubelle, MS | 1 |
| Laplanche, A | 3 |
| Inai, H | 1 |
| Kawai, K | 5 |
| Kojima, T | 1 |
| Joraku, A | 1 |
| Shimazui, T | 4 |
| Yamauchi, A | 1 |
| Miyagawa, T | 1 |
| Endo, T | 1 |
| Fukuhara, Y | 1 |
| Miyazaki, J | 2 |
| Uchida, K | 2 |
| Nishiyama, H | 1 |
| Deville, JL | 1 |
| Flechon, A | 6 |
| Bruyère, F | 1 |
| Karsenty, G | 1 |
| Guy, L | 1 |
| Bastide, C | 1 |
| Schummer, C | 1 |
| Winkler, Y | 1 |
| Tittelbach, J | 1 |
| Grimm, MO | 1 |
| Elsner, P | 1 |
| Gravis, G | 3 |
| Laguerre, B | 1 |
| Eymard, JC | 2 |
| Houede, N | 1 |
| Burcoveanu, D | 1 |
| Chovanec, M | 1 |
| Mego, M | 2 |
| Sycova-Mila, Z | 3 |
| Obertova, J | 2 |
| Rajec, J | 1 |
| Palacka, P | 1 |
| Mardiak, J | 4 |
| Tanaka, H | 1 |
| Yuasa, T | 1 |
| Fujii, Y | 2 |
| Sakura, M | 1 |
| Urakami, S | 1 |
| Yamamoto, S | 1 |
| Masuda, H | 2 |
| Fukui, I | 4 |
| Yonese, J | 4 |
| Jeong, Y | 1 |
| Cheon, J | 1 |
| Kim, TO | 1 |
| Lim, DH | 1 |
| Lee, S | 2 |
| Cho, YM | 1 |
| Hong, JH | 1 |
| Lee, JL | 1 |
| Haas, R | 1 |
| Teske, C | 1 |
| Schönberger, S | 1 |
| Schneider, DT | 1 |
| Leuschner, I | 1 |
| Harms, D | 1 |
| Pagliaro, L | 2 |
| Theodore, C | 5 |
| Roubaud, G | 1 |
| Linassier, C | 1 |
| Habibian, M | 1 |
| Martin, AL | 1 |
| Journeau, F | 1 |
| Reckova, M | 2 |
| Logothetis, C | 1 |
| Joly, C | 1 |
| Deblock, M | 1 |
| Desandes, E | 1 |
| Nieto, Y | 1 |
| Tu, SM | 1 |
| Bassett, R | 1 |
| Jones, RB | 1 |
| Gulbis, AM | 1 |
| Tannir, N | 1 |
| Kingham, A | 1 |
| Ledesma, C | 1 |
| Margolin, K | 2 |
| Holmberg, L | 1 |
| Champlin, R | 1 |
| Fresneau, B | 1 |
| Castex, MP | 1 |
| Lauritsen, J | 1 |
| Kier, MG | 1 |
| Mortensen, MS | 1 |
| Bandak, M | 1 |
| Gupta, R | 1 |
| Holm, NV | 1 |
| Agerbaek, M | 1 |
| Daugaard, G | 2 |
| Gallo, K | 1 |
| Brickman, A | 1 |
| Warren, WH | 1 |
| Gattuso, P | 1 |
| Seder, CW | 1 |
| Lopes, LF | 1 |
| Macedo, CR | 1 |
| Aguiar, Sdos S | 1 |
| Barreto, JH | 1 |
| Martins, GE | 1 |
| Sonaglio, V | 1 |
| Milone, M | 1 |
| Lima, ER | 1 |
| Almeida, MT | 1 |
| Lopes, PM | 1 |
| Watanabe, FM | 1 |
| D'Andrea, ML | 1 |
| Pianovski, MA | 1 |
| Melaragno, R | 1 |
| Vianna, SM | 1 |
| Moreira, ME | 1 |
| Bruniera, P | 1 |
| de Oliveira, CZ | 1 |
| Ranganath, P | 1 |
| Kesler, KA | 1 |
| Lorch, A | 4 |
| Beyer, J | 16 |
| Pagliaro, LC | 1 |
| Zschäbitz, S | 1 |
| Lasitschka, F | 1 |
| Hadaschik, B | 1 |
| Hofheinz, RD | 1 |
| Jentsch-Ullrich, K | 1 |
| Grüner, M | 1 |
| Jäger, D | 1 |
| Grüllich, C | 1 |
| Kollmannsberger, C | 6 |
| Bokemeyer, C | 21 |
| Mesa, H | 1 |
| Rawal, A | 1 |
| Rezcallah, A | 1 |
| Iwamoto, C | 1 |
| Niehans, GA | 1 |
| Druck, P | 1 |
| Gupta, P | 1 |
| Riese, MJ | 1 |
| Vaughn, DJ | 1 |
| Conrad, AL | 1 |
| Go, RS | 1 |
| Troost, MM | 1 |
| Sternberg, CN | 1 |
| de Wit, R | 4 |
| Ishioka, J | 2 |
| Kageyama, Y | 3 |
| Inoue, M | 1 |
| Fukui, N | 1 |
| Numao, N | 1 |
| Saito, K | 1 |
| Ichiyanagi, N | 2 |
| Tanak, M | 1 |
| Hyochi, N | 1 |
| Fukuda, H | 2 |
| Higashi, Y | 2 |
| Skoneczna, I | 1 |
| Aass, N | 2 |
| De Santis, M | 1 |
| Dumez, H | 1 |
| Marreaud, S | 1 |
| Collette, L | 2 |
| Lluch, JRG | 1 |
| Schmoll, HJ | 18 |
| Ohno, M | 1 |
| Narita, Y | 1 |
| Keskin, S | 1 |
| Ekenel, M | 1 |
| Başaran, M | 1 |
| Aksu, C | 1 |
| Kiliçaslan, I | 1 |
| Tunç, M | 1 |
| Bavbek, S | 1 |
| Sneag, DB | 1 |
| Ramaiya, N | 1 |
| O'Regan, KN | 1 |
| Jagannathan, JP | 1 |
| Hornick, JL | 1 |
| Ho, VT | 1 |
| Hayes, JH | 1 |
| Fedyanin, M | 1 |
| Tryakin, A | 1 |
| Kanagavel, D | 1 |
| Bulanov, A | 1 |
| Burova, A | 1 |
| Figurin, K | 1 |
| Fainshtein, I | 1 |
| Sergeev, U | 1 |
| Zakharova, T | 1 |
| Garin, A | 1 |
| Tjulandin, S | 1 |
| Park, S | 1 |
| Lee, J | 1 |
| Park, SH | 1 |
| Park, JO | 1 |
| Kang, WK | 1 |
| Park, YS | 1 |
| Lim, HY | 1 |
| Haugnes, HS | 1 |
| Laurell, A | 1 |
| Stierner, U | 1 |
| Bremnes, RM | 1 |
| Dahl, O | 1 |
| Cavallin-Ståhl, E | 1 |
| Cohn-Cedermark, G | 1 |
| Kleinhans, A | 1 |
| Kramar, A | 3 |
| Kollmannsberger, CK | 1 |
| Hartmann, JT | 9 |
| Rick, O | 10 |
| Onesti, E | 1 |
| Fabi, A | 1 |
| Mingoia, M | 1 |
| Savarese, A | 1 |
| Anelli, V | 1 |
| Koudriavtseva, T | 1 |
| Rashid, S | 1 |
| Lim, L | 1 |
| Powles, T | 1 |
| Frøen, H | 1 |
| Brennhovd, B | 1 |
| Abeler, VM | 1 |
| Madsbu, UE | 1 |
| Lehne, G | 1 |
| Krege, S | 2 |
| Massard, C | 1 |
| Pico, JL | 2 |
| Rosti, G | 1 |
| Droz, JP | 10 |
| Kobayashi, T | 1 |
| Hangaishi, A | 1 |
| Yamamoto, G | 1 |
| Shinohara, A | 1 |
| Morikawa, T | 1 |
| Takazawa, Y | 1 |
| Ota, S | 1 |
| Imai, Y | 1 |
| Nakamura, F | 1 |
| Kurokawa, M | 1 |
| Porcaro, AB | 1 |
| Antoniolli, SZ | 1 |
| Maffei, N | 1 |
| Beltrami, P | 1 |
| Bassetto, MA | 1 |
| Curti, P | 1 |
| Stewart, RJ | 1 |
| Oberlin, O | 1 |
| Rey, A | 1 |
| Bouvet, N | 1 |
| Spicer, RD | 1 |
| Godzinski, J | 1 |
| Stevens, MC | 1 |
| Tsukamoto, S | 2 |
| Hinotsu, S | 1 |
| Hattori, K | 2 |
| Akaza, H | 6 |
| Oldenburg, J | 1 |
| Alfsen, GC | 1 |
| Lien, HH | 1 |
| Waehre, H | 1 |
| Fossa, SD | 3 |
| Motzer, RJ | 7 |
| Sheinfeld, S | 1 |
| Metzner, B | 9 |
| Schleucher, N | 2 |
| Schöffski, P | 1 |
| Schleicher, J | 6 |
| Hossfeld, D | 1 |
| Kanz, L | 4 |
| Berdel, WE | 3 |
| Andreesen, R | 1 |
| Kita, M | 1 |
| Sasaki, Y | 1 |
| Okuyama, M | 1 |
| Saga, Y | 1 |
| Hashimoto, H | 1 |
| Kaneko, S | 1 |
| Yachiku, S | 1 |
| Tokumitsu, M | 1 |
| Inada, F | 1 |
| Ishida, H | 1 |
| Dietrich, J | 1 |
| Marienhagen, J | 1 |
| Schalke, B | 1 |
| Bogdahn, U | 1 |
| Schlachetzki, F | 1 |
| Ishikawa, T | 1 |
| Kamidono, S | 2 |
| Fujisawa, M | 3 |
| Ishizuka, O | 1 |
| Satoh, T | 1 |
| Mizuno, H | 1 |
| Mizusawa, H | 1 |
| Seki, S | 1 |
| Nishizawa, O | 1 |
| Tanji, S | 1 |
| Obara, W | 1 |
| Sugimura, J | 1 |
| Ohmori, S | 1 |
| Matsushita, Y | 1 |
| Tokunaga, H | 1 |
| Konda, R | 1 |
| Fujioka, T | 1 |
| Murai, K | 1 |
| Ishida, Y | 1 |
| Stenning, S | 1 |
| Horwich, A | 1 |
| Clemm, C | 6 |
| Gerl, A | 3 |
| Meisner, C | 1 |
| Rückerl, CP | 1 |
| Oliver, T | 1 |
| Weinknecht, S | 2 |
| Schirren, J | 1 |
| Pottek, T | 1 |
| Braun, T | 1 |
| Rachud, B | 1 |
| Weissbach, L | 3 |
| Hartmann, M | 1 |
| Siegert, W | 12 |
| Lamerz, R | 1 |
| Stieber, P | 1 |
| Wierecky, J | 1 |
| Boehlke, I | 1 |
| Kuczyk, M | 1 |
| Lotz, JP | 3 |
| Bui, B | 1 |
| Gomez, F | 1 |
| Peny, J | 1 |
| Viens, P | 1 |
| Duclos, B | 1 |
| De Revel, T | 1 |
| Curé, H | 1 |
| Gligorov, J | 2 |
| Guillemaut, S | 1 |
| Ségura, C | 1 |
| Provent, S | 1 |
| Biron, P | 3 |
| Miki, T | 6 |
| Mikami, K | 2 |
| Mizutani, Y | 4 |
| Farmakis, D | 1 |
| Pectasides, M | 1 |
| Pectasides, D | 1 |
| Yoshinaga, A | 1 |
| Hayashi, T | 1 |
| Ishii, N | 1 |
| Ohno, R | 1 |
| Watanabe, T | 1 |
| Yamada, T | 1 |
| Mead, GM | 2 |
| Cullen, MH | 1 |
| Huddart, R | 1 |
| Harper, P | 1 |
| Rustin, GJ | 1 |
| Cook, PA | 1 |
| Stenning, SP | 1 |
| Mason, M | 1 |
| Kondagunta, GV | 1 |
| Bacik, J | 2 |
| Donadio, A | 1 |
| Bajorin, D | 2 |
| Marion, S | 1 |
| Sheinfeld, J | 2 |
| Bosl, GJ | 5 |
| Sálek, T | 2 |
| Hlavatá, Z | 1 |
| Koza, I | 2 |
| Takizawa, A | 1 |
| Miura, T | 1 |
| Fujinami, K | 1 |
| Osada, Y | 1 |
| Tanaka, M | 1 |
| Maruta, I | 1 |
| Taue, R | 1 |
| Harada, A | 1 |
| Katto, K | 1 |
| Yamamoto, Y | 1 |
| Kishimoto, T | 1 |
| Nakatuji, Y | 1 |
| Tanimoto, S | 1 |
| Oka, N | 1 |
| Izaki, H | 1 |
| Fukumori, T | 1 |
| Takahashi, M | 1 |
| Nishitani, M | 1 |
| Kanayama, HO | 1 |
| Nomoto, T | 1 |
| Nakamura, T | 1 |
| Nakanishi, H | 1 |
| Kawauchi, A | 1 |
| Shigemura, K | 1 |
| Tanaka, K | 1 |
| Hara, I | 5 |
| Muramaki, M | 1 |
| Arakawa, S | 2 |
| Takaoka, E | 1 |
| Naoi, M | 1 |
| Mori, K | 1 |
| Minami, M | 1 |
| Miyake, H | 2 |
| Yamada, Y | 2 |
| Yamanaka, K | 2 |
| Furukawa, J | 1 |
| Kumano, M | 1 |
| Takenaka, A | 1 |
| Ozono, S | 2 |
| Tsukamoto, T | 4 |
| Terachi, T | 3 |
| Naito, K | 2 |
| Nonomura, N | 3 |
| Yoshida, O | 3 |
| Oka, D | 1 |
| Nishimura, K | 1 |
| Nakayama, M | 1 |
| Inoue, H | 1 |
| Okuyama, A | 1 |
| Schmidt-Wolf, IG | 1 |
| Weissinger, F | 1 |
| Egerer, G | 1 |
| Haas, A | 1 |
| Schirren, R | 1 |
| vom Dorp, F | 1 |
| Rübben, H | 1 |
| Kondagunta, V | 1 |
| Galsky, MD | 1 |
| Sonpavde, G | 1 |
| Gauler, T | 1 |
| Casper, J | 5 |
| Horger, M | 1 |
| Derigs, G | 2 |
| Mayer-Steinacker, R | 1 |
| Kuczyk, MA | 1 |
| Kume, H | 1 |
| Kakutani, S | 1 |
| Tomita, K | 1 |
| Kitamura, T | 1 |
| Yanada, S | 2 |
| Ito, H | 1 |
| Tomita, M | 2 |
| Wada, T | 1 |
| Hatano, T | 1 |
| Kishimoto, K | 1 |
| Egawa, S | 1 |
| Arnold, H | 1 |
| Fiebig, HH | 1 |
| Hartlapp, JH | 2 |
| Jaeger, N | 2 |
| Fischer, P | 1 |
| Steinke, B | 1 |
| Heidemann, E | 1 |
| Ostendorf, P | 1 |
| Wilms, K | 1 |
| Waller, HD | 1 |
| Schwabe, HW | 1 |
| Adolphs, HD | 1 |
| Hartlapp, J | 2 |
| Wegener-Höpfner, U | 1 |
| Schmidt, RE | 1 |
| Niese, D | 1 |
| Madej, G | 1 |
| Porwit-Ksiazek, A | 1 |
| Siedlecki, P | 1 |
| Zborzil, J | 1 |
| Holoye, PY | 1 |
| Anderson, T | 1 |
| Duelge, J | 1 |
| Hansen, RM | 1 |
| Ritch, PS | 1 |
| Seeber, S | 6 |
| Dimitriadis, K | 1 |
| Schütte, J | 3 |
| Schmidt, CG | 4 |
| Hacke, M | 1 |
| Alt, JM | 1 |
| Baumann, K | 1 |
| Stolte, H | 2 |
| Scheulen, ME | 5 |
| Niederle, N | 5 |
| Bremer, K | 2 |
| Watson, RA | 1 |
| Cremer, M | 1 |
| Burkert, H | 3 |
| Hunter, HL | 1 |
| Harrison, EF | 1 |
| Loehrer, PJ | 7 |
| Williams, SD | 6 |
| Hartenstein, R | 3 |
| Wilmanns, W | 2 |
| Krischke, W | 1 |
| Higi, M | 1 |
| Dieckmann, KP | 2 |
| Loy, V | 2 |
| Onishi, T | 1 |
| Nakano, S | 1 |
| Yanagawa, M | 1 |
| Sugimura, Y | 1 |
| Tochigi, H | 1 |
| Kawamura, J | 1 |
| Broun, ER | 2 |
| Nichols, CR | 5 |
| Turns, M | 1 |
| Roth, BJ | 2 |
| Lazarus, HM | 2 |
| Head, MD | 1 |
| Pfaller, W | 1 |
| Thorwartl, U | 1 |
| Nevinny-Stickel, M | 1 |
| Krall, M | 1 |
| Schober, M | 1 |
| Joannidis, M | 1 |
| Hobisch, A | 1 |
| Simmonds, PD | 1 |
| Whitehouse, JM | 1 |
| Goan, SR | 1 |
| Fichtner, I | 1 |
| Just, U | 1 |
| Karawajew, L | 1 |
| Schultze, W | 1 |
| Krause, KP | 1 |
| von Harsdorf, S | 1 |
| von Schilling, C | 1 |
| Herrmann, F | 1 |
| Vicente, P | 1 |
| Garciá del Muro, X | 2 |
| Cardenal, F | 1 |
| Elias, AD | 1 |
| Ayash, LJ | 1 |
| Wheeler, C | 1 |
| Schwartz, G | 1 |
| Tepler, I | 1 |
| Gonin, R | 1 |
| McCauley, M | 1 |
| Mazanet, R | 1 |
| Schnipper, L | 1 |
| Frei, E | 1 |
| Rodriguez, E | 1 |
| Reuter, VE | 1 |
| Mazumdar, M | 3 |
| Chaganti, RS | 1 |
| Harstrick, A | 7 |
| Rüther, U | 1 |
| Illiger, HJ | 4 |
| Link, H | 1 |
| Ostermann, H | 3 |
| André, T | 2 |
| Donsimoni, R | 1 |
| Firmin, C | 1 |
| Bouleuc, C | 2 |
| Bonnak, H | 1 |
| Merad, Z | 1 |
| Esteso, A | 1 |
| Gerota, J | 1 |
| Izrael, V | 2 |
| Fields, KK | 1 |
| Elfenbein, GJ | 1 |
| Cooper, BW | 1 |
| Perkins, JB | 1 |
| Creger, RJ | 1 |
| Ballester, OF | 1 |
| Hiemenz, JH | 1 |
| Janssen, WE | 1 |
| Zorsky, PE | 1 |
| Stoter, G | 4 |
| Kaye, SB | 3 |
| Vermeylen, K | 1 |
| Sylvester, R | 2 |
| Strohscheer, I | 1 |
| Baurmann, H | 1 |
| Oettle, H | 1 |
| Zingsem, J | 1 |
| Zimmermann, R | 1 |
| Huhn, D | 3 |
| Räth, U | 3 |
| Hohnloser, J | 2 |
| Berdel, W | 2 |
| Ludwig, E | 1 |
| Dunn, T | 2 |
| Stewart, DA | 1 |
| Stewart, DJ | 1 |
| Mai, KT | 1 |
| Kneba, M | 1 |
| Kynast, B | 1 |
| Poliwoda, H | 2 |
| Barnett, MJ | 1 |
| Coppin, CM | 1 |
| Murray, N | 1 |
| Nevill, TJ | 1 |
| Reece, DE | 1 |
| Klingemann, HG | 1 |
| Shepherd, JD | 1 |
| Nantel, SH | 1 |
| Sutherland, HJ | 1 |
| Phillips, GL | 1 |
| Quezado, ZM | 1 |
| Wilson, WH | 1 |
| Cunnion, RE | 1 |
| Parker, MM | 1 |
| Reda, D | 1 |
| Bryant, G | 1 |
| Ognibene, FP | 1 |
| Lee, PK | 1 |
| Dover, JS | 1 |
| Farhat, F | 1 |
| Békradda, M | 2 |
| Terrier-Lacombe, MJ | 1 |
| Amato, RJ | 1 |
| Ellerhorst, J | 1 |
| Banks, M | 1 |
| Logothetis, CJ | 1 |
| Doroshow, JH | 1 |
| Ahn, C | 1 |
| Hamasaki, V | 1 |
| Leong, L | 1 |
| Morgan, R | 1 |
| Raschko, J | 1 |
| Shibata, S | 1 |
| Somlo, G | 1 |
| Tetef, M | 1 |
| Péne, F | 1 |
| Gattegno, B | 1 |
| Bazelly, B | 1 |
| Houry, S | 1 |
| Chapiro, J | 1 |
| Selle, F | 1 |
| Fels, LM | 1 |
| Voigt, W | 1 |
| Gaedeke, J | 1 |
| Lentzen, H | 1 |
| Kingreen, D | 4 |
| Krause, M | 1 |
| Schwaner, I | 1 |
| Schwella, N | 3 |
| Gize, G | 1 |
| Cornetta, K | 1 |
| Hromas, RA | 1 |
| Schacht, B | 1 |
| Oliver, RT | 1 |
| McCaffrey, JA | 1 |
| Bajorin, DF | 2 |
| Vlamis, V | 1 |
| Brennemann, W | 1 |
| Stoffel-Wagner, B | 1 |
| Helmers, A | 1 |
| Mezger, J | 1 |
| Jäger, N | 1 |
| Klingmüller, D | 1 |
| Herlofson, BB | 1 |
| Norman-Pedersen, K | 1 |
| Redfors, M | 1 |
| Lenz, K | 1 |
| Takahashi, A | 1 |
| Miyao, N | 1 |
| Masumori, N | 1 |
| Takeda, K | 1 |
| Shigyo, M | 1 |
| Sasamura, H | 1 |
| Sakamaki, S | 1 |
| Niitsu, Y | 1 |
| Kihara, K | 1 |
| Kamata, S | 1 |
| Tsujii, T | 1 |
| Ishizaka, K | 1 |
| Arisawa, C | 1 |
| Oshima, H | 1 |
| Komatsu, F | 1 |
| Sleijfer, DT | 1 |
| Neijt, JP | 1 |
| ten Bokkel Huinink, WW | 1 |
| de Prijck, L | 1 |
| Akasaka, Y | 1 |
| Madarame, J | 1 |
| Igarashi, H | 1 |
| Kuroda, A | 1 |
| Nakata, J | 1 |
| Ohishi, Y | 1 |
| Kondou, N | 1 |
| Muraki, O | 1 |
| Itoh, M | 1 |
| Haga, N | 1 |
| Tsuruya, Y | 1 |
| Honda, K | 1 |
| Yamaguchi, O | 1 |
| Ohto, H | 1 |
| Maeda, Y | 3 |
| Oyama, H | 1 |
| Shishido, T | 2 |
| Kin, T | 3 |
| Izutani, T | 2 |
| Nakagawa, K | 1 |
| Okumura, S | 1 |
| Hiratsuka, H | 1 |
| Krusch, A | 1 |
| Kirsch, A | 1 |
| Gysler, J | 1 |
| Schunack, W | 1 |
| Jaehde, U | 1 |
| Gupta, NP | 1 |
| Agrawal, AK | 1 |
| Sood, S | 1 |
| Hemal, AK | 1 |
| Nair, M | 1 |
| Kitsukawa, S | 2 |
| Philip, I | 1 |
| Blay, JY | 1 |
| Germà-Lluch, JR | 1 |
| Tabernero, JM | 1 |
| Sánchez, M | 1 |
| Aparicio, J | 1 |
| Alba, E | 1 |
| Barnadas, A | 1 |
| Kellner, O | 1 |
| Dempke, W | 1 |
| Ganjoo, KN | 1 |
| Chan, RJ | 1 |
| Sharma, M | 1 |
| Nomi, M | 1 |
| Hara, S | 1 |
| Takechi, Y | 1 |
| Oka, Y | 1 |
| Nakamura, I | 1 |
| Gotoh, A | 1 |
| Gohji, K | 1 |
| Soulié, P | 1 |
| Garrino, C | 1 |
| Bensmaïne, MA | 1 |
| Brain, E | 1 |
| Di Palma, M | 1 |
| Goupil, A | 1 |
| Misset, JL | 1 |
| Cvitkovic, E | 1 |
| Saiki, S | 1 |
| Meguro, N | 1 |
| Maeda, O | 1 |
| Kinouchi, T | 1 |
| Kuroda, M | 1 |
| Usami, M | 1 |
| Kotake, T | 1 |
| Kawakita, M | 1 |
| Matsuda, T | 1 |
| Nakagawa, S | 1 |
| Okano, T | 1 |
| Sonoda, Y | 1 |
| Naito, S | 1 |
| Nishiyama, T | 1 |
| Hoshi, S | 1 |
| Yoshida, T | 1 |
| Bisogno, G | 1 |
| Roganovich, J | 1 |
| Sotti, G | 1 |
| Ninfo, V | 1 |
| di Montezemolo, LC | 1 |
| Donfrancesco, A | 1 |
| Mascarin, M | 1 |
| Carli, M | 1 |
| Bains, M | 1 |
| Mariani, T | 1 |
| de Bono, JS | 1 |
| Paul, J | 1 |
| Simpson, A | 1 |
| Anthoney, A | 1 |
| Kirk, D | 1 |
| Underwood, M | 1 |
| Graham, J | 1 |
| Fuchsberger, P | 1 |
| Lakota, J | 1 |
| Drahokoupilová, M | 1 |
| Baláz, M | 1 |
| Neureither, S | 1 |
| Wandt, H | 1 |
| Hartmann, F | 1 |
| Peterson, AC | 1 |
| Porter, M | 1 |
| Porter, J | 1 |
| Miyanaga, N | 1 |
| Körner, F | 2 |
| Lund, S | 1 |
| Jonas, U | 1 |
| Ritter, S | 1 |
| Schröder, HJ | 1 |
| Schnitker, J | 2 |
| Fichtner, E | 2 |
| Hartwich, G | 1 |
| Neidhardt, B | 1 |
| Lutz, H | 1 |
| Brock, N | 2 |
| Vahlensieck, W | 1 |
| Pizzocaro, G | 1 |
| Salvioni, R | 1 |
| Piva, L | 1 |
| Faustini, M | 1 |
| Nicolai, N | 1 |
| Gianni, L | 1 |
| Saxman, S | 1 |
| Wandl, UB | 2 |
| Günzel, K | 1 |
| Kath, R | 2 |
| Hayungs, J | 1 |
| Höffken, K | 1 |
| Zidar, BL | 1 |
| Metch, B | 1 |
| Balcerzak, SP | 1 |
| Pierce, HI | 1 |
| Militello, L | 1 |
| Keppen, MD | 1 |
| Berenberg, JL | 1 |
| Wilke, H | 2 |
| Köhne-Wömpner, CH | 2 |
| Stahl, M | 1 |
| Schöber, C | 1 |
| Bruderek, L | 1 |
| Schmoll, E | 1 |
| Weiss, RB | 1 |
| Manegold, C | 1 |
| Köhne-Wömpner, H | 1 |
| van der Gaast, A | 1 |
| Hoekstra, JW | 1 |
| Croles, JJ | 1 |
| Splinter, TA | 1 |
| Bergmann, L | 1 |
| Lammers, U | 1 |
| Dölken, G | 1 |
| Reichhardt, P | 1 |
| Natt, F | 1 |
| Blanco Guerrero, R | 1 |
| Germà Lluch, JR | 1 |
| Climent Durán, MA | 1 |
| Mercedes Ramírez, A | 1 |
| Alonso Muñoz, C | 1 |
| López Pousa, A | 1 |
| López López, JJ | 1 |
| Falkson, G | 1 |
| Chasen, MR | 1 |
| Falkson, HC | 1 |
| Cooper, K | 1 |
| Geller, NL | 1 |
| Dmitrovsky, E | 1 |
| Herr, H | 1 |
| Morse, M | 1 |
| Fair, W | 1 |
| Sogani, P | 1 |
| Russo, P | 1 |
| Freund, M | 1 |
| De Boben, M | 1 |
| Diedrich, H | 1 |
| Ganser, A | 1 |
| Heil, G | 1 |
| Heyll, A | 1 |
| Henke, M | 1 |
| Hiddemann, W | 1 |
| Knauf, U | 1 |
| Koch, P | 1 |
| Kreuser, ED | 1 |
| Altwein, JE | 1 |
| Egghart, G | 1 |
| Gaus, W | 1 |
| Schreml, W | 1 |
| Sleijfer, D | 1 |
| Jones, W | 1 |
| Ten Bokkel Huinink, W | 1 |
| Splinter, T | 1 |
| Van Oosterom, A | 1 |
| Harris, A | 1 |
| Boven, E | 1 |
| De Pauw, M | 1 |
| Sauer, H | 1 |
| Nightingale, SL | 1 |
| Ribrag, V | 1 |
| Ghosn, M | 2 |
| Guimares, J | 1 |
| Azab, M | 1 |
| Ostronoff, M | 2 |
| Mahjoubi, M | 1 |
| Moran, A | 2 |
| Pico, J | 1 |
| Bodrogi, I | 1 |
| Baume, D | 1 |
| Spielmann, M | 1 |
| Salloum, E | 1 |
| Li, GC | 1 |
| Li, JQ | 1 |
| Guan, ZZ | 1 |
| He, YJ | 1 |
| Zalupski, M | 1 |
| Baker, LH | 1 |
| Wheeler, BM | 1 |
| Willich, N | 1 |
| Boening, L | 1 |
| Brade, WP | 1 |
| Herdrich, K | 1 |
| Varini, M | 1 |
| Hoefer, H | 1 |
| Scheef, W | 1 |
| Titscher, R | 1 |
| Kokron, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Multicenter Phase II Trial of Gemcitabine, Cisplatin, and Ifosfamide (GIP) in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors (NSGCT) and a Predicted Favorable Prognosis[NCT00127049] | Phase 2 | 37 participants | Interventional | 2004-12-31 | Recruiting | ||
| A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors[NCT00104676] | Phase 3 | 263 participants (Actual) | Interventional | 2003-11-26 | Active, not recruiting | ||
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors[NCT00936936] | Phase 2 | 64 participants (Actual) | Interventional | 2009-06-02 | Active, not recruiting | ||
| A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer[NCT00003941] | Phase 3 | 222 participants (Anticipated) | Interventional | 1999-04-30 | Completed | ||
| A Multi-Centre Phase II Study Using Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT[NCT02272816] | Phase 2 | 48 participants (Actual) | Interventional | 2012-02-13 | Completed | ||
| Sequential High-Dose Chemotherapy Combining Two Mobilization and Cyto-Reductive Treatments Followed by Three High-Dose Chemotherapy Regimens Supported by Autologous Stem Cell Transplantation[NCT00231582] | Phase 2 | 50 participants (Actual) | Interventional | 2004-09-30 | Completed | ||
| A Study of Paclitaxel, Cisplatin and Ifosfamide as Induction Therapy in the Treatment of Patients Relapsing After BEP Chemotherapy for Metastatic Germ Cell Tumors[NCT00004077] | Phase 2 | 25 participants (Anticipated) | Interventional | 1996-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To evaluated the overall survival in both groups in participants presenting fast and slow decrease in serum levels of tumor markers. The median overall survival was defined as the median percentage of participants alive after 1 course of treatment. (NCT00104676)
Timeframe: 3 years from randomization
| Intervention | percentage of participants (Number) |
|---|---|
| Arm I | 65 |
| Arm II | 73 |
Primary objective is to compare the progression-free survival of participants after 1 cycle of treatment, treated randomly by 3 additional cycles of BEP (Arm I) or by T-BEP-Oxaliplatin/cisplatin-ifosfamide-Bleomycin (Arm II). The median progression-free survival rate was defined as the median percentage of participants alive without disease progression after 1 course of treatment. (NCT00104676)
Timeframe: 3 years from randomization
| Intervention | percentage of participants (Number) |
|---|---|
| Arm I | 48 |
| Arm II | 59 |
Number of participants progression free 2 years after registration. (NCT02272816)
Timeframe: 2 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Carboplatin AUC-10 | 46 |
40 reviews available for ifosfamide and Cancer of Testis
| Article | Year |
|---|---|
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Eto | 2022 |
Placental Site Trophoblastic Tumor in Nonseminomatous Mixed Germ Cell Tumors of the Testis: a Case Report and Review of the Literature.
Topics: Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryo | 2018 |
Current medical management of patients with poor-risk metastatic germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; | 2018 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisp | 2013 |
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Dose-Response Relati | 2017 |
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality | 2017 |
Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dose-Response R | 2008 |
Chemotherapy for patients with poor prognosis germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; | 2009 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2009 |
Management of good risk germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials a | 2009 |
High-dose chemotherapy in nonseminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; | 2009 |
Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Fatal O | 2012 |
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neop | 2012 |
[PEB treatment of testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combin | 2012 |
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin | 2002 |
[Pulmonary rhabdomyosarcoma generated during treatment of testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Combined Mod | 2003 |
Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Corpus Callosum; Etoposide; Germin | 2004 |
[The second-line chemotherapy for urological cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship | 2005 |
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Drug | 2005 |
[Testis germ cell tumours: which chemotherapy, for which patients?].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti | 2007 |
Ifosfamide: European perspective.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administrat | 1982 |
The anticancer spectrum of ifosfamide.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Mal | 1982 |
Response of metastasized sex cord gonadal stromal tumor of the testis to cisplatin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifos | 1994 |
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Chemotherapy, Adjuvant; Cis | 1994 |
Ifosfamide in the treatment of germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 1996 |
The role of ifosfamide in the treatment of testicular and urothelial malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials as Top | 1996 |
[Salvage therapy for refractory testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Hum | 1996 |
Future trials in germ cell malignancy (GCM) of the testis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopl | 1997 |
Malignant mesothelioma of the tunica vaginalis testis: a report of two cases and review of literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Drug Admin | 1999 |
Salvage chemotherapy in relapsed germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; | 2001 |
[Treatment of metastatic testicular carcinoma according to prognosis; new development].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Dr | 2001 |
[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; | 2001 |
[Chemotherapy and radiotherapy for urological cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administrati | 2002 |
Clinical trials with ifosfamide: the Indiana University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Indiana; | 1992 |
Salvage therapy in recurrent testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Cyclophosphamide; | 1992 |
Ifosfamide in testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Etoposide; Humans; Ifosfa | 1990 |
The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Huma | 1988 |
The role of ifosfamide in testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dysgerminoma; Humans; I | 1989 |
Ifosfamide.
Topics: Breast Neoplasms; Drug Evaluation, Preclinical; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphoma | 1988 |
Ifosfamide--pharmacology, safety and therapeutic potential.
Topics: Animals; Biotransformation; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evalu | 1985 |
64 trials available for ifosfamide and Cancer of Testis
| Article | Year |
|---|---|
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration | 2014 |
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomark | 2014 |
Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Ch | 2015 |
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EO
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T | 2011 |
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, | 2012 |
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Topics: Adult; alpha-Fetoproteins; Biomarkers, Tumor; Carboplatin; Chorionic Gonadotropin; Cisplatin; Cyclop | 2013 |
Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Admini | 2003 |
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer S
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Ther | 2003 |
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carb | 2004 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Surviva | 2005 |
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Resistance, Neopla | 2005 |
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Dose-Respons | 2005 |
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Germinoma; Humans; Ifosfamide; Mal | 2005 |
Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Th | 2007 |
Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Topics: Acute Kidney Injury; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; An | 2007 |
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophos | 2007 |
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relation | 2007 |
[Side-effects of polychemotherapy in metastatic testicular neoplasms (author's transl)].
Topics: Adult; Alopecia; Anemia; Bleomycin; Ceruletide; Cisplatin; Constipation; Cyclophosphamide; Drug Ther | 1982 |
[Chemotherapy of nonseminomatous testicular tumors. The results of a pilot study with reduced cis-platin dosage].
Topics: Bleomycin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; | 1983 |
[Clinical evaluation of ifosfamide in one-agent chemotherapy of malignant testicular tumors].
Topics: Adolescent; Adult; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cyclophosphamide; Follow | 1982 |
Use and safety of high-dose ifosfamide.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyc | 1982 |
Ifosfamide: European perspective.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administrat | 1982 |
Serum tumor marker half-life during chemotherapy in patients with germ cell tumors.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gon | 1994 |
Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury.
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Alpha-Globulins; Antineoplastic Agents; Antin | 1994 |
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Digesti | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carb | 1995 |
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 1995 |
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; | 1995 |
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etopo | 1994 |
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte-Macroph | 1993 |
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Granulocyte-Macrophage Colony- | 1993 |
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carb | 1993 |
High-dose ifosfamide is associated with severe, reversible cardiac dysfunction.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bone | 1993 |
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; | 1996 |
Carboplatin and ifosfamide and selective consolidation in advanced seminoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modal | 1995 |
Early utilization of high-dose chemotherapy in germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Protocols; Etoposide; Germinom | 1996 |
Sequential intermediate high-dose chemotherapy in the primary treatment of poor risk testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Gra | 1996 |
The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Th | 1996 |
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide | 1997 |
Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cross-Secti | 1997 |
Paclitaxel in salvage therapy for germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 1997 |
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bo | 1997 |
Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Etoposi | 1998 |
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG)
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplasti | 1999 |
Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Combined Modal | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Ch | 1999 |
[Results of chemotherapy and salvage surgery for advanced testicular cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Mo | 1999 |
[High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Car | 1999 |
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Germ | 2000 |
Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Ther | 2000 |
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 2001 |
[Clinical experience with the cytostatic drug ifosfamide].
Topics: Adolescent; Adult; Aged; Bleomycin; Carcinoma; Clinical Trials as Topic; Cyclophosphamide; Drug Ther | 1977 |
Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Child; Clinical Trials as Topic; Cyclopho | 1976 |
Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relation | 1992 |
Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: long-term results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topi | 1992 |
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Male; Mesna | 1992 |
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Ad | 1991 |
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifo | 1990 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl | 1990 |
The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Huma | 1988 |
Potential advances in combination chemotherapy for advanced testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etop | 1988 |
Ifosfamide in refractory male germ cell tumors.
Topics: Acetylcysteine; Adult; Clinical Trials as Topic; Drug Administration Schedule; Dysgerminoma; Follow- | 1986 |
Ifosfamide--pharmacology, safety and therapeutic potential.
Topics: Animals; Biotransformation; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evalu | 1985 |
[Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
Topics: Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Female; Humans | 1974 |
124 other studies available for ifosfamide and Cancer of Testis
| Article | Year |
|---|---|
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Eto | 2023 |
Para-neoplastic optic neuritis presenting in a child with fusion positive localised para-testicular alveolar rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blindness; Cyclophosphamide; Doxorubicin | 2021 |
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluid Therapy; Hematopoietic | 2017 |
Durable Response to Immune Checkpoint Blockade in a Platinum-Refractory Patient With Nonseminomatous Germ Cell Tumor.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamid | 2017 |
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasm | 2017 |
Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Neoplasms, | 2017 |
Pure Seminoma and Concurrent Aggressive Lymphoma: Case Report of a Patient With Persistent Müllerian Duct Syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disorder of Sex Development, 46,XY | 2019 |
Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule | 2013 |
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin | 2015 |
Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Drug | 2014 |
A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Surviv | 2014 |
Oncological outcomes of metastatic testicular cancers under centralized management through regional medical network.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Man | 2013 |
[Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor].
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; D | 2014 |
Adenocarcinoma of the rete testis - a rare case of testicular malignancy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Filgrastim; Granulocyte C | 2014 |
First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era.
Topics: Adult; Antineoplastic Agents; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide | 2013 |
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; | 2015 |
Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 2014 |
[Primary mediastinal germs cells tumors: a twenty years experience in a comprehensive cancer center].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Cisplatin; | 2014 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; C | 2015 |
Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cisplatin; Datab | 2015 |
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; H | 2015 |
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Su | 2016 |
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2016 |
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothera | 2017 |
"Burned out" testicular seminoma presenting as a primary gastric malignancy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; D | 2009 |
[Result of treatment for advanced germ cell tumor in the last decade].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cis | 2010 |
A case of pathological complete remission of a brain metastasis from germ cell tumor of the testis after systemic chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Chor | 2010 |
The first case of primary testicular germ cell tumor containing nephroblastoma as the only one non-germ cell component.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; | 2011 |
Peritoneal relapse of testicular seminomatous germ cell tumor treated successfully with salvage chemotherapy and autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Pa | 2011 |
Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2013 |
Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Disease-Free | 2011 |
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Mo | 2012 |
[Young man with severe back pain].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differe | 2012 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexame | 2013 |
Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 2003 |
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chi-Squar | 2003 |
Poor-risk testicular cancer and high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Ger | 2003 |
Fertility after high-dose chemotherapy for testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality The | 2004 |
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma | 2004 |
[Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin | 2004 |
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Disease-Free Survival; Et | 2004 |
[Tumour markers--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosph | 2004 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etopo | 2005 |
Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Dermatomyosi | 2005 |
[A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Ci | 2005 |
[Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Com | 2006 |
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sc | 2006 |
Clinical study for management of supportive treatment for high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for intractable testicular tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combi | 2006 |
A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Drug A | 2006 |
Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin | 2006 |
Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Humans; Ifosfam | 2007 |
[Inductive systemic therapy of urological tumors with curative intent].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Mo | 2007 |
Germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Hem | 2007 |
Salvage combination chemotherapy with docetaxel, ifosfamide and cisplatin (DIP): successful treatment of a case with metastatic testicular immature teratoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Ifosfamide; Lun | 2008 |
[A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic | 2008 |
[Modern chemotherapy of a malignant testicular tumors (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinatio | 1981 |
Flow-cytophotometric studies on urine sediments of patients treated with anti-cancer-drugs.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide | 1983 |
[Long-term changes in the immune system following cytostatic polychemotherapy in patients with testicular tumors in remission].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Immune System; Immunoglob | 1984 |
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bro | 1984 |
Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment.
Topics: Albuminuria; alpha-Glucosidases; beta 2-Microglobulin; Cisplatin; Cyclophosphamide; Drug Interaction | 1983 |
Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
Topics: Cyclophosphamide; Drug Evaluation; Drug Interactions; Female; Humans; Ifosfamide; Male; Mercaptoetha | 1983 |
Ifosfamide: chemotherapy with new promise and new problems for the urologist.
Topics: Acetylcysteine; Cyclophosphamide; Cystitis; Female; Hemorrhage; Humans; Ifosfamide; Kidney Neoplasms | 1984 |
Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; | 1983 |
N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
Topics: Acetylcysteine; Adenocarcinoma; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combin | 1983 |
The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy.
Topics: Adolescent; Adult; Alkylating Agents; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Humans | 1982 |
Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
Topics: Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Male; Podophyllotoxin; T | 1982 |
[Initial chemotherapy followed by orchiectomy and retroperitoneal lymphadenectomy--a case of seminoma with a testicular tumor and enlarged regional lymph nodes].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 1994 |
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
A complicated case of metastatic teratoma. Growing teratoma syndrome and cerebral metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cispl | 1995 |
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone | 1995 |
[Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etopos | 1995 |
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma | 1995 |
The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Screening Assays, Antitumor; Humans; I | 1994 |
Active chemotherapy for metastatic stromal cell tumor of the testis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Head and Neck Neop | 1993 |
Intratesticular effects of cisplatin-based chemotherapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Pr | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Com | 1995 |
Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration.
Topics: Acne Vulgaris; Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic | 1996 |
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etopo | 1996 |
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; Disease Models, A | 1996 |
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1997 |
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, | 1997 |
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
Treatment for advanced testicular cancer with high-dose chemotherapy and autologous blood stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplas | 1998 |
[High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) For advanced testicular cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Ad | 1998 |
[High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration S | 1998 |
[A case of neutropenic enterocolitis in high dose chemotherapy with peripheral blood stem cell transplantation for relapsed testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Enter | 1998 |
[Successful management for chemorefractory testicular cancer with brain and lung metastases. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinoma, Embryonal; | 1998 |
High-dose chemotherapy in germ cell tumours: a large single centre experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Surviva | 1998 |
Monitoring of chemotherapy-induced proteinuria using capillary zone electrophoresis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buffers; Calibration; Carboplatin; Electropho | 1999 |
[Two cases of giant testicular tumor with widespread extension to the spermatic cord: usefulness of upfront chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposi | 1999 |
[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin | 1999 |
[Glucose infusions--a possible effective therapeutic option in ifosfamide-induced encephalopathy].
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Germinoma; | 1999 |
Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Male; Me | 1999 |
[Treatment of advanced testicular cancer and toxicity of chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; | 1999 |
[Treatment results of VIP (etoposide, ifosfamide and cisplatin) chemotherapy as a first-line therapy in metastatic germ cell tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifos | 2000 |
Desmoplastic small round cell tumour in children and adolescents.
Topics: Abdominal Neoplasms; Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Ant | 2000 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gona | 2000 |
Adult testicular sarcoma: presentation, evaluation, and treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Male; Middle Aged; | 2002 |
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etop | 2001 |
[Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)].
Topics: Adult; Antineoplastic Agents; Bleomycin; Cell Transformation, Neoplastic; Child; Child, Preschool; D | 1975 |
Chemotherapy in testicular tumors.
Topics: Bleomycin; Castration; Cell Division; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; D | 1977 |
[Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
Topics: Adolescent; Adult; Aged; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Gastrointestinal Dise | 1979 |
[Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
Topics: Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
The combined surgical and chemotherapeutic approach to non-seminomatous cancer of the testicle.
Topics: Chlorambucil; Dactinomycin; Drug Therapy, Combination; Dysgerminoma; Humans; Ifosfamide; Lymph Node | 1977 |
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Ad | 1991 |
Ifosfamide vs cyclophosphamide in cancer therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Female; Genital Neoplasms, | 1991 |
Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Cisplatin; Doxorubicin; Epirubicin; Humans; Ifosfam | 1990 |
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropi | 1991 |
Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Mo | 1991 |
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Iatrogenic | 1991 |
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1990 |
Bulky germinal tumors: comparison of different induction regimens and significance of residual disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Humans; Ifosfamid | 1985 |
[Treatment of stage I-IIB nonseminomatous testicular tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Mo | 1989 |
From the Food and Drug Administration.
Topics: Acyclovir; Anilides; Cytomegalovirus Infections; Flutamide; Ganciclovir; Humans; Ifosfamide; Male; M | 1989 |
Ifosfamide in testicular cancer: the Indiana University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Etoposide; Humans; Ifo | 1989 |
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etopo | 1989 |
Third-line chemotherapy of resistant advanced testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Dysgerminoma; Etoposide; Humans; | 1989 |
Ifosfamide and mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cystitis; Hemorrhage; Humans; Ifosfamide; Male; Merc | 1989 |
Ifosfamide approved for treatment of testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Male; Testicular Neoplasms | 1989 |
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etopo | 1988 |
Ifosfamide and Mesna in advanced malignancies.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Lymphom | 1988 |
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Female; Humans; Ifosfami | 1986 |
Vinblastine-ifosfamide-cisplatin treatment of bulky seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysgerminoma; Humans; Ifosfamide; | 1986 |
VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Humans; Ifosfamide; Kidn | 1986 |